Clinical Trial Update: Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without Pacing Indications [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports results from evaluating optimal anti-tachycardia therapy in implantable cardioverter-defibrillator patients without pacing ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tachycardia

Snippet

Sponsor: LivaNova | Conditions: Tachycardia | Phase 4 | Status: COMPLETED